Rapidly progressive glomerulonephritis (RPGN) is a rare clinical condition, and its incidence varies between 4 and 10 per cent in all renal biopsy series[@ref1]. It is commonly characterized morphologically by the extensive crescent formation in the Bowman\'s space[@ref2]. Crescentic glomerulonephritis (GN) histopathologically consists of three types on immunofluorescent microscopy; type 1, linear deposition of immunoglobulin G (IgG) throughout the glomerular basement membrane (GBM; anti-GBM disease); type 2, granular deposits (immune complex disease); and type 3, absence of immunoglobulins is characteristic of pauci-immune GN seen in patients with systemic vasculitis[@ref3]. The severity of the disease is related to the degree of crescent formation; patients with circumferential crescents in more than 80 per cent of the glomeruli tend to present with advanced renal failure and may not respond to immunosuppressive therapy. On the other hand, patients with crescents in \<50 per cent of the glomeruli, particularly if the crescents are non-circumferential, typically follow a more indolent cruising and may even undergo a remission. The stage of active inflammation characterized by cellular crescents is often followed by the development of fibrocellular and fibrous crescents[@ref3]. This transition is important clinically because fibrous crescents represent a stage of the disease that is not likely to respond to immunosuppressive therapy. If left untreated, crescentic GN has an invariably poor outcome, most of the patients' progress to end-stage renal disease (ESRD) or death within months. Therefore, the process from diagnosis to treatment must be rapidly and carefully planned. However, despite aggressive treatment, development of ESRD and dependence on dialysis are likely to occur.

The current knowledge about the factors affecting renal prognosis guides the physicians to further individualize the treatment and by this way, ameliorate the treatment-related morbidity and mortality. Factors deemed to be predictive of prognosis are time interval from the beginning of complaints to diagnosis, presence of oliguria or anuria, increased serum creatinine level at admission, dialysis dependence on admission, a crescent rate higher than 80 per cent of glomeruli, fibrinoid necrosis, anti-GBM antibodies in GBM, tubular atrophy and interstitial fibrosis[@ref1][@ref4]. However, there is no consensus on prognostic factors that would predict renal outcome.

Total leucocyte count provides a crude but sensitive assessment of inflammatory status, with low cost and wide availability. It has been demonstrated that some specific subtypes of leucocytes have higher predictive value in assessing cardiovascular risk and poor prognosis in several disorders than total white blood cell (WBC) count itself. The neutrophil-to-lymphocyte ratio (NLR) is a marker of poor prognosis in several disorders such as malignancies, chronic kidney disease and myocardial infarction[@ref5][@ref6][@ref7][@ref8]. Besides, the platelet-to-lymphocyte ratio (PLR) is associated with poor prognosis in many diseases such as acute coronary syndrome and breast cancer[@ref9][@ref10][@ref11]. Previous studies showed that both NLR and PLR were markers of inflammation in ESRD patients[@ref11][@ref12][@ref13].

Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are the acute phase reactants used in the clinical evaluation of disease activity in crescentic GN; however, their roles in predicting the extent of disease involvement or prognosis are limited. This study was aimed to investigate the roles of NLR and PLR in predicting the extent of clinical involvement and prognosis of patients with RPGN.

Material & Methods {#sec1-2}
==================

Consecutive newly diagnosed RPGN patients who had a follow up for at least six months between January 2005 and June 2016 at Manisa Celal Bayar University, Internal Medicine-Nephrology Clinic, Manisa, Turkey were retrospectively analyzed. The control group consisted of age- and sex-matched normotensive patients who presented to the same clinic during the same period with non-inflammatory conditions and without kidney disease.

*Renal biopsy and laboratory parameters:* Renal biopsy reports of all the 578 biopsy-proven patients were screened. The presence of at least one cellular or fibrocellular crescent was an inclusion criterion for the study. Standard processing of renal biopsies included light microscopy and immunofluorescence. The diagnosis was established by clinicopathologic correlation. The medical records of the patients were examined and clinical data including demographic details, presenting clinical and laboratory findings, treatment, and follow up data were obtained. Details of treatment and clinical outcomes (including renal function, proteinuria, dialysis status, inflammatory markers, and mortality) were collected at admission, after one, six months and one and five years and at the last follow up. The estimated glomerular filtration rate (eGFR) was calculated by the Modification of Diet in Renal Disease Study equation[@ref14]. Decreased eGFR was defined as \<60 ml/min/1.73 m[@ref2].

In addition to inflammation, the assessment of patient nutritional status could also aid in assessing disease activity[@ref15][@ref16]. For this reason, besides the albumin and CRP values, the CRP albumin ratio of the patients was also calculated.

The study was approved by the Ethics Committee of Manisa Celal Bayar University.

*Statistical analysis:* Statistical analysis was conducted using Statistical Package for the Social Sciences version 15.0 (SPSS Inc., Chicago, IL, USA) Frequencies for categorized data type (qualitative) variations and standard error of mean for continuous data type (quantitative) variation were calculated. In case of categorized data type variations (renal biopsy histopathological findings), Chi-square test \[if one of the variables was continuous variable (haematological parameters) and distribution was appropriate\], t test or one-way ANOVA parametric tests were used. If the distribution was inappropriate non-parametric tests (Kruskal--Wallis and Mann--Whitney U-test) were used. If both variables had continuous data, considering the distribution of variable, parametric (Pearson 'r') or non-parametric (Spearmen p) correlation tests were used.

Results {#sec1-3}
=======

A total of 54 patients \[19 women (35%) and 35 men (65%)\] were included in the patient group. The mean age of the patients was 48.92±20.12, and that of control group (n=44) was 49.16±10.59 years. Clinicopathological diagnosis was pauci-immune GN in 40 cases (74%) while two had post-infectious GN, six systemic lupus erythematosus, three IgA nephropathy, two Henoch--Schönlein purpura, and one had membranoproliferative GN. Twenty three (42%) patients needed haemodialysis at the time of diagnosis. During five years of follow up, 18 (33%) patients developed ESRD. As comes to mortality five of total six patients died in the first year. Three had a diagnosis of Wegener granulomatosis, one had microscopic PAN, in two cases mortality was considered to be due to extrarenal systems involvement.

*Correlations of NLR, PLR and laboratory parameters:* NLR and PLR were significantly higher in the patients group compared with the control group. The mean NLR was 7.02±0.86 versus 1.74±0.11 (*P*\<0.001) and mean PLR was 273.90±39.15 versus 99.68±5.26 (*P*\<0.05), respectively. Baseline characteristics of the patients and control groups are shown in [Table I](#T1){ref-type="table"}. Positive correlations were observed between NLR and CRP levels (*P*=0.009, *r*=0.511) and CRP/albumin ratios (*P*=0.005, *r*=0.542). While PLR and CRP/albumin ratios (*P*=0.041, *r*=0.412) were correlated positively, PLR and albumin (*P*=0.032, *r*=−0.293) had a negative correlation.

###### 

Demographic, clinical and laboratory features of the patients with rapidly progressive glomerulonephritis and control group

  Variables                         Mean±SE                  
  --------------------------------- ------------------------ --------------------
  Age (yr)                          48.92±2.73               49.16±2.12
  Systolic blood pressure (mmHg)    128.98±2.61              117.60±4.96
  Diastolic blood pressure (mmHg)   79.16±1.47               77.16±1.76
  White blood cell (10^3^/μl)       9720.18±587.70^\*\*\*^   6455.60±310.15
  Neutrophil (10^3^/μl)             7420.93±395.17^\*\*\*^   4050.83±218.18
  Lymphocyte (10^3^/μl)             1401.48±91.20^\*\*\*^    2466.80±127.96
  Platelet count (10^3^/μl)         277962.96±13749.66       234920.00±10361.94
  Haemoglobin (g/dl)                10.04±0.24^\*\*\*^       13.92±0.36
  Haematocrit (%)                   30.07±0.71^\*\*\*^       42.13±0.92
  NLR                               7.02±0.86^\*\*\*^        1.74±0.11
  PLR                               273.90±39.15^\*^         99.68±5.26
  Glucose (mg/dl)                   101.37±2.84              102.60±7.36
  Blood urea nitrogen (mg/dl)       50.74±3.05^\*\*\*^       12.25±0.60
  Creatinine (mg/dl)                4.09±0.36^\*\*\*^        0.78±0.32
  Albumin (g/dl)                    2.76±0.10^\*\*\*^        4.28±0.76
  CRP (mg/dl)                       61.97±14.39^\*\*\*^      2.70±0.24
  CRP/albumin ratio                 24.22±5.94^\*\*\*^       0.64±0.60
  MDRD-GFR                          34.39±4.05^\*\*\*^       103.55±4.33
  Ferritin (ng/ml)                  375.12±64.61             \-
  Proteinuria (mg/gün)              4327.33±682.02           \-
  Haematuria (/HPF)                 185.76±50.67             \-

*P*^\*^\<0.05, ^\*\*\*^\<0.001 compared to control. NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; CRP, C-reactive protein; MDRD, modification of diet in renal disease; GFR, glomerular filtration rate; SD, standard deviation, HPF, high-power field

*Primary and secondary crescentic glomerulonephritis (GN) subgroup analysis:* The subgroup analysis was performed with respect to the aetiopathogenesis as primary and secondary crescentic GN. There were 40 patients in the primary crescentic GN and 14 in the secondary crescentic GN subgroup. ESR and CRP were the acute phase reactants used in the clinical evaluation of disease activity in primary crescentic GN. Due to the retrospective nature of the study, ESR values could not be obtained in all patients. In primary crescentic GN group, 15 patients were cytoplasmic antineutrophil cytoplasmic antibodies (C-ANCA) positive, 14 patients were perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) positive and 11 patients were ANCA negative. There was a significant difference between the primary and secondary crescentic GN groups with respect to the baseline neutrophil, WBC and CRP levels. However, there was not any significant difference in NLR and PLR values between the subgroups ([Table II](#T2){ref-type="table"}).

###### 

Comparison of patients in the primary and secondary crescentic glomerulonephritis sub-groups at baseline

  Variables                     Mean±SE               
  ----------------------------- --------------------- --------------------
  Age (yr)                      52.22±2.83^\*\*^      36.64±5.76
  White blood cell (10^3^/μl)   10337.50±652.78^\*^   7957.14±1206.68
  Neutrophil (10^3^/μl)         7919.50±620.04^\*^    5996.42±1027.67
  Lymphocyte (10^3^/μl)         1457.50±106.01        1241.42±178.34
  Platelet count (10^3^/μl)     286400.00±18012.20    253857.14±11474.22
  Hemoglobin (g/dl)             9.89±0.25             10.49±0.60
  Haematocrit (%)               29.57±0.72            31.53±1.81
  NLR                           6.77±0.70             7.74±2.73
  PLR                           244.17±23.58          358.84±136.35
  Blood urea nitrogen (mg/dl)   53.22±3.42            43.64±6.38
  Creatinine (mg/dl)            4.49±0.40^\*\*^       2.97±0.72
  Albumin (g/dl)                2.89±0.11^\*^         2.42±0.22
  CRP (mg/dl)                   72.89±16.09^\*^       4.62±4.17
  CRP/albumin ratio             28.41±6.71^\*^        2.24±1.65
  MDRD-GFR                      26.62±4.01^\*\*^      56.64±8.27
  Ferritin (ng/ml)              453.58±79.54^\*\*^    131.00±31.16
  Proteinuria (mg/gün)          4027.33±803.12        3912.32±1325.78
  Haematuria (/HPF)             165.76±68.88          157.54±32.05

*P*^\*^\<0.05, ^\*\*^\<0.01 compared to secondary crescentic patients

*Renal biopsy histopathological findings:* According to the renal biopsy histopathological findings, 25 patients had diffused crescentic GN (crescents in more than 50% of the glomerulus). Twenty three of them were in the primary crescentic GN subgroup. While the percentage of crescents was 49 per cent in primary crescentic GN cases, this ratio was 31 per cent in secondary GN cases. There was no correlation between crescent ratio and haematological parameters in subgroups. In primary crescentic group, 23 patients had diffused crescentic and 17 had focal crescentic GN. There was no significant difference in the haematological parameters according to the diffuse-focal crescentic GN.

There was no correlation between renal biopsy histopathological findings and gender, age, progression to ESRD and mortality. There were significant correlations between the per cent of both sclerotic and fibrocellular crescents and dialysis dependency at the admission. The per cent of cellular crescents and dialysis dependency had nearly significant correlation. The relationship between renal biopsy histopathological findings and dialysis dependency is shown in [Table III](#T3){ref-type="table"}.

###### 

Relationship between renal biopsy histopathological findings and dialysis dependency at admission

  Histopathology findings   Dialysis dependency   Mean±SE
  ------------------------- --------------------- ------------
  Sclerotic glomeruli       Dependent (n=23)      3.30±1.32
  Independent (n=31)        1.61±0.34             
  Cellular crescent         Dependent (n=23)      39.39±6.69
  Independent (n=31)        16.70±3.36            
  Fibrosellular crescent    Dependent (n=23)      19.17±5.45
  Independent (n=31)        10.51±2.49            
  Fibrous crescent          Dependent (n=23)      3.17±1.63
  Independent (n=31)        4.25±1.82             
  Fibrinoid necrosis        Dependent (n=23)      19.52±6.06
  Independent (n=31)        10.45±3.54            

*P*^\*^\<0.05, ^\*\*^\<0.01, ^\*\*\*^\<0.001 compared to dialysis independent group

While the per cent of fibrocellular crescents and NLR (*P*=0.033, *r*=−0.291) were negatively correlated, the same histopathological finding showed a positive correlation with the lymphocyte count (*P*=0.042, *r*=0.256). There was significant negative correlation between cellular crescent per cent and haematocrit (*P*=0.049, *r*=−0.269) ([Table IV](#T4){ref-type="table"}). In primary crescentic subgroup NLR showed a negative correlation with the per cent of fibrocellular crescents (*P*=0.041, *r*=−0.324). In secondary crescentic subgroup the per cent of fibrinoid necrosis had a positive correlation with PLR (*P*=0.013, *r*=0.642) and negative correlation with the lymphocyte count (*P*=0.011, *r*=−0.657) and haematocrit value (*P*=0.043, *r*=−0.548).

###### 

Correlation between renal biopsy histopathological findings and haematological parameters

  Histopathological Parameters   Sclerotic glomeruli   Cellular crescent   Fibrocellular crescent   Fibrous crescent   Fibrinoid necrosis                                     
  ------------------------------ --------------------- ------------------- ------------------------ ------------------ -------------------- ------- -------- ------- -------- -------
  White blood cell               −0.026                0.850               0.040                    0.775              −0.128               0.356   0.023    0.868   −0.015   0.912
  Neutrophil                     0.049                 0.728               0.053                    0.753              −0.186               0.185   0.017    0.903   0.037    0.793
  Lymphocyte                     0.178                 0.198               0.021                    0.879              0.256                0.042   0.192    0.164   −0.229   0.096
  Platelet                       0.084                 0.545               0.098                    0.481              0.039                0.780   0.021    0.878   −0.006   0.966
  Haemoglobin                    0.151                 0.275               −0.210                   0.127              −0.096               0.491   0.007    0.962   −0.238   0.083
  Haematocrit                    0.132                 0.343               −0.269                   0.049              −0.105               0.449   −0.026   0.850   −0.217   0.115
  RDW                            −0.310                0.023               0.021                    0.882              −0.185               0.181   −0.223   0.106   −0.047   0.735
  NLR                            −0.186                0.178               −0.006                   0.966              −0.291               0.033   −0.068   0.625   0.140    0.312
  PLR                            −0.177                0.200               −0.005                   0.970              −0.136               0.327   −0.128   0.356   0.218    0.114

RDW, red cell distribution width

The neutrophil score (based on neutrophil count per crescentic glomerulus) was divided into three subgroups: 0, 1-2 and ≥3. The neutrophil score was found to be higher in cases with higher creatinine (*P*\<0.05) and ferritin (*P*\<0.05) levels and lower plasma sodium (*P*\<0.05) concentrations at the time of diagnosis. Interstitial inflammation was graded into three subgroups: \<25, between 25 and 50 and, \>50 per cent. As interstitial inflammation increased, ferritin levels (*P*\<0.01) were higher while plasma sodium (*P*\<0.05) concentrations were lower. A significant (*P*\<0.01) relationship was observed between interstitial inflammation and dialysis need at the time of admission. While dialysis need was 30.4 per cent in \<25 per cent interstitial inflammation, it increased to 33.3 per cent in the 25-50 per cent and 76.9 per cent in the \>50 per cent interstitial inflammation subgroups, respectively. The degree of haematuria was highest in \<25 per cent and lowest in 25-50 per cent interstitial inflammation subgroups (*P*\<0.05).

On the basis of renal biopsy features, corticosteroid-cyclophosphamide was co-administered in 41 patients, sole corticosteroid treatment was given in 12 while to one patient no treatment was given because of established chronic changes in renal biopsy specimen. Twenty (37%) patients were observed to enter into remission and five who needed dialysis initially became independent from dialysis at the sixth month. Both NLR and PLR detected at the first month of the treatment period, were observed to be significantly (*P*\<0.05) correlated with mortality.

Discussion {#sec1-4}
==========

This study demonstrated that NLR could predict mortality in patients with RPGN, correlated with systemic inflammation, showed a negative correlation with the per cent of fibrocellular crescents. In secondary crescentic subgroup fibrinoid necrosis showed a positive correlation with PLR and negative correlation with the lymphocyte count and haematocrit value. PLR can be an indicator of disease severity in acute phase of crescentic GN. A negative correlation between NLR and the per cent of fibrocellular crescents was supported by a positive correlation between the per cent of fibrocellular crescents and lymphocyte count which itself is a measure of chronic inflammation. The positive correlation between neutrophil count in crescentic glomeruli and ferritin concentration shows that glomerular inflammation in RPGN is so severe that it can cause systemic inflammation and activates acute phase reactants.

RPGN is a rare but severe clinical condition. Although prognosis in some RPGN subtypes has improved, yet progression to ESRD is frequent. This figure was 33 per cent in our study. Since RPGN is both a glomerular and systemic inflammatory process, activation of systemic inflammatory markers is accompanied by inflammatory findings in renal biopsy specimens. In our study, patients had prominent hypoalbuminemia, exhibited increased CRP levels and CRP/albumin ratios. Anaemia was also evident in our patients and accompanied by increased ferritin levels reflecting systemic inflammation. NLR and PLR values were significantly higher in comparison to control group. In a study conducted by Aydın *et al*[@ref17], NLR was found to be 1.94±0.98 in men, 2.05±1.05 in women aged between 40 and 49 in healthy group. These ratios tended to be higher in older individuals and reached 2.5-3 in those \>70 years of age. In comparison to reference values and control group, our ratios showed two-three fold increase. Nagy *et al*[@ref18] have found the median NLR ratio as 5.9 (4.3-7.1) in cases with systemic involvement while cases with non-systemic involvement median NLR was only 2.6 (1.6-3) (*P*\<0.001) in a retrospective study of involving 40 IgA vasculitis patients. Their patients were divided into three subgroups; renal involvement, gastrointestinal (GI) tract involvement and combined renal and GI tract involvement. The highest NLR was found in combined renal and GI tract involvement (7.4±3.4) subgroup. Emiroglu *et al*[@ref19] compared NLR values of 45 vasculitic cases (cutaneous or combined cutaneous and systemic) at the time of cutaneous biopsy-proven with the values of 40 healthy cases. NLR, CRP, and ESR values were found to be higher in the vasculitis group. Ozcicek *et al*[@ref20] showed that NLR levels were significantly higher in haemodialysis patients than in the healthy control group and it was found to be an independent predictor of epicardial adipose tissue in haemodialysis patients. Küçük *et al*[@ref21] found NLR significantly correlated with ESR and CRP levels and related to disease activity in a study of 53 granulomatosis with polyangiitis patients.

In our study, NLR and CRP-CRP/albumin ratio were found to be positively correlated. Nagy *et al*[@ref18] have detected positive correlations between NLR and CRP, ESR. In many studies, NLR and PLR were positively correlated with inflammation in ESRD patients[@ref12][@ref13].

NLR has been demonstrated to be an independent risk factor for cardiovascular diseases. Turkmen *et al*[@ref22] have shown significant correlation between NLR and coronary artery and thoracic peri-aortic calcification score (TACS) in 56 ESRD patients. Inflammation has been found to be an important contributor of increased atherosclerosis and vascular calcification in previous studies which is frequently seen in ESRD patients[@ref23][@ref24][@ref25]. Turkmen *et al*[@ref22] also demonstrated that NLR and age were independent predictors of TACS. No correlation was observed between renal biopsy histopathological findings and gender, age, progression to ESRD and death. While the per cent of both sclerotic glomeruli and fibrocellular crescents were significantly related to dialysis dependency at the time of admission, the relationship was not significant between the number of cellular crescents and dialysis dependency at the time of admission. It can be speculated that increased numbers of fibrocellular and sclerotic glomeruli reflect more severe and irreversible disease state thus necessitating dialysis, while cellular crescents reflect severe inflammatory disease but implying a component of reversibility thus a lesser degree of relationship with the dialysis need at the time of admission. Fibrocellular crescent number positively correlated with lymphocyte count, negatively correlated with NLR suggesting that increased numbers of fibrocellular crescents reflected the underlying chronic inflammatory state. A significant negative correlation between cellular crescent count and haematocrit can be a reflection of the severity of the underlying inflammation. In the secondary crescentic subgroup fibrinoid necrosis positively correlated with PLR. This showed that PLR might be a predictor of the acute stage of the disease. The PLR was found to be a better predictor of mortality than NLR due to all causes in chronic haemodialysis patients in the context of inflammation and renal failure[@ref26]. In the present study significant positive correlations were found between NLR (*P*\<0.05), PLR (*P*\<0.05) values and death at the end of the first month.

Interstitial inflammation was positively correlated with hyperferritinemia and hyponatremia, strongly correlated with dialysis need at the time of admission. The positive correlation between interstitial inflammation and hyperferritinemia might be explained by more intense systemic inflammation related to interstitial inflammation. Increased degrees of interstitial inflammation might have resulted in severe kidney dysfunction thus necessitating dialysis.

Our study had two main limitations. First, primary and secondary crescentic glomerulonephritis patients evaluated together and a relatively small number of secondary subgroup existed. Second, the sample was not homogeneous, and the sample size was relatively small. Another limitation was that because of retrospective nature of the study ESR values could not be obtained.

Prospective studies with a higher number of patients and subgroups (primary, secondary, comprising patients due to vasculitis, glomerular disease, and drug-induced) are needed to assess PLR and NLR value in severity scaling, predicting response to treatment and disease progression of the RPGN. Additional studies investigating the possible association with inflammatory cytokines could be designed.

To conclude, our findings showed that the NLR-PLR markers might be used to grade glomerular inflammation, NLR and PLR correlated with histopathological findings obtained from renal biopsy specimens, and most importantly NLR was associated with mortality in RPGN cases. Although cause-effect relationship between NLR and prognosis could not be substantiated, this ratio might be considered as an economic marker-epiphenomenon that could predict clinical hard-points in RPGN cases.
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